eFFECTOR Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering the discovery and development of a new class of oncology drugs known as selective translation regulators (STRs).

Biotechnology

eFFECTOR Therapeutics

eFFECTOR Therapeutics' headquarters in San Diego, CA, United States

Steve Worland

Doug Warner

Kapil Dhingra

Jennifer A. Doudna

Funda Meric-Bernstam

Robert Schneider

Robert Sikorski

Joan Brugge

Neal Rosen

Kevan Shokat

Davide Ruggero

Sarat Chandarlapaty

Kristen Harrington-Smith

Caroline Loewy

The Advisory Team at eFFECTOR Therapeutics comprises highly experienced professionals who provide strategic guidance and expert insights to support the discovery and development of selective translation regulators (STRs). Their collective expertise ensures the company’s oncology drugs progress effectively through clinical stages, aligning with eFFECTOR’s mission and regulatory standards.

Advisory Team

The Leadership Team at eFFECTOR Therapeutics guides the strategic direction and operational execution of the company’s mission to innovate cancer therapies. Comprising experts in clinical development, pharmacology, and translational science, the team collaborates to oversee research initiatives, drive regulatory strategies, and ensure the successful progression of selective translation regulators (STRs) through the clinical pipeline.

Leadership Team

��

eFFECTOR Therapeutics

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

��������

eFFECTOR Therapeutics

Org chart

Board & advisors

Teams

Advisory Team

Leadership Team

Offices

Related companies

��